LCTX Next Earnings Date Notes

— Lineage Cell Therapeutics (LCTX) is a clinical-stage biotechnology company focusing on the development of novel cellular therapies to address serious unmet medical needs, primarily in the fields of ophthalmology, neurology, & oncology. The company’s pipeline includes promising products such as OpRegen—a retinal pigment epithelium cell therapy for dry age-related macular degeneration (dry AMD)—as well as cell therapies targeting spinal cord injuries & cancer. For an investor, key business metrics to track include the progress & timing of clinical trial milestones (especially for OpRegen in both the U.S. & internationally), strategic partnership updates, licensing deals, and any data on safety & efficacy from ongoing or upcoming studies. Equally important are the company’s cash runway, operating expenses, and R&D spending, as these affect Lineage’s ability to finance its pipeline through critical development stages. During earnings calls, pay particular attention to management’s comments on partnership opportunities (especially with larger biopharma), regulatory updates, and guidance on expected data releases, as these will shape long-term growth prospects and valuation. The next projected earnings date for LCTX is 5/12/2026 after close (stay tuned for a confirmed earnings date once announced).

LCTX Next Earnings Date FAQ

On this page we presented the LCTX Next Earnings Date information for Lineage Cell Therapeutics along with recent past earnings dates. For Q4 of 2025, LCTX reported earnings of 0.004/share, with the earnings report taking place on 3/5/2026. For Q3 of 2025, LCTX reported earnings of -0.130/share, with the earnings report taking place on 11/6/2025. For Q2 of 2025, LCTX reported earnings of -0.070/share, with the earnings report taking place on 8/12/2025. For Q1 of 2025, LCTX reported earnings of -0.020/share, with the earnings report taking place on 5/13/2025. For Q4 of 2024, LCTX reported earnings of -0.020/share, with the earnings report taking place on 3/10/2025. Based on these past earnings dates, the projected next earnings date for LCTX is 5/12/2026 after market close.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as Lineage Cell Therapeutics. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to Lineage Cell Therapeutics shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research Lineage Cell Therapeutics next earnings dates as well as any other stock out there in our coverage universe, to see when the next LCTX earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up LCTX's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the LCTX next earnings date.